Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation

Alka Mansukhani1, Davide Ambrosetti, Greg Holmes

  • 1Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA. mansua01@med.nyu.edu

Insights

Activating fibroblast growth factor receptor 2 (FGFR2) mutations disrupt bone development. FGF signaling induces Sox2, inhibiting osteoblast differentiation and Wnt pathway activity, impacting craniosynostosis syndromes.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Genetics

Background:

  • Activating mutations in fibroblast growth factor receptor 2 (FGFR2) are linked to craniosynostosis syndromes.
  • FGFR2 signaling influences osteoblast proliferation and differentiation, crucial for calvarial bone formation.

Purpose of the Study:

  • To investigate the molecular mechanisms by which FGFR2 mutations affect osteoblast gene expression.
  • To elucidate the role of Sox2 in mediating the effects of FGF signaling on osteoblast differentiation and Wnt pathway activity.

Main Methods:

  • Gene expression profiling of osteoblasts with activating FGFR2 mutations (C342Y, S252W).
  • Treatment of osteoblasts with exogenous FGF to mimic mutation effects.
  • Analysis of Sox2 expression, osteoblast differentiation markers, and Wnt target gene activity.
  • Co-immunoprecipitation to assess Sox2 and beta-catenin interaction.

Main Results:

  • FGFR2 mutations and FGF treatment down-regulated Wnt target genes and induced Sox2 expression in osteoblasts.
  • Constitutive Sox2 expression inhibited osteoblast differentiation and Wnt target gene expression.
  • Sox2 associated with beta-catenin and inhibited Wnt pathway reporter activity.

Conclusions:

  • FGF signaling regulates osteoblast differentiation, partly through Sox2 induction.
  • Sox2 plays a critical role in suppressing osteoblast differentiation by interfering with the Wnt-beta-catenin pathway.
  • These findings offer insights into the pathogenesis of FGFR2-related craniosynostosis syndromes.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...